<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clin Mol Hepatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Clin Mol Hepatol</journal-id>
      <journal-id journal-id-type="publisher-id">CMH</journal-id>
      <journal-title-group>
        <journal-title>Clinical and Molecular Hepatology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2287-2728</issn>
      <issn pub-type="epub">2287-285X</issn>
      <publisher>
        <publisher-name>The Korean Association for the Study of the Liver</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27044771</article-id>
      <article-id pub-id-type="pmc">4825159</article-id>
      <article-id pub-id-type="doi">10.3350/cmh.2016.22.1.183</article-id>
      <article-id pub-id-type="publisher-id">cmh-22-1-183</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jwa</surname>
            <given-names>Hye Young</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cmh-22-1-183">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>Yoo-Kyung</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cmh-22-1-183">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Choi</surname>
            <given-names>Eun Kwang</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cmh-22-1-183">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Heung Up</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cmh-22-1-183">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Hyun Joo</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cmh-22-1-183">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Na</surname>
            <given-names>Soo-Young</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cmh-22-1-183">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Boo</surname>
            <given-names>Sun-Jin</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cmh-22-1-183">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jeong</surname>
            <given-names>Seung Uk</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cmh-22-1-183">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Bong Soo</given-names>
          </name>
          <xref ref-type="aff" rid="af2-cmh-22-1-183">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Byoung-Wook</given-names>
          </name>
          <xref ref-type="aff" rid="af3-cmh-22-1-183">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Byung-Cheol</given-names>
          </name>
          <xref ref-type="corresp" rid="c1-cmh-22-1-183"/>
          <xref ref-type="aff" rid="af1-cmh-22-1-183">
            <sup>1</sup>
          </xref>
        </contrib>
        <aff id="af1-cmh-22-1-183"><label>1</label>Department of Internal Medicine, Jeju National University School of Medicine, Jeju, <country>Korea</country></aff>
        <aff id="af2-cmh-22-1-183"><label>2</label>Department of Radiology, Jeju National University School of Medicine, Jeju, <country>Korea</country></aff>
        <aff id="af3-cmh-22-1-183"><label>3</label>Department of Internal Medicine, Yeollin Hospital, Jeju, <country>Korea</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1-cmh-22-1-183">Corresponding author : Byung-Cheol Song Department of Internal Medicine, Jeju National University School of Medicine, 15 Aran 13-gil, Jeju 63241, Korea Tel: +82-64-754-7177, Fax: + 82-64-717-1131. E-mail: <email>drsong8177@naver.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <volume>22</volume>
      <issue>1</issue>
      <fpage>183</fpage>
      <lpage>187</lpage>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>4</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>11</day>
          <month>5</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>5</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016 by The Korean Association for the Study of the Liver</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license>
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Recent studies suggest that liver cirrhosis is reversible after administering oral nucleos(t)ide analogue therapy to patients with hepatitis B virus (HBV) infection. However, few studies have addressed whether esophageal varices can regress after such therapy. We report a case of complete regression of esophageal varices during entecavir therapy in patients with HBV-related liver cirrhosis, suggesting that complications of liver cirrhosis such as esophageal varices can regress after the long-term suppression of HBV replication.</p>
      </abstract>
      <kwd-group>
        <kwd>Hepatitis B virus</kwd>
        <kwd>Entecavir</kwd>
        <kwd>Esophageal varices</kwd>
        <kwd>Liver cirrhosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Hepatitis B virus (HBV) infection is a worldwide public health problem. It is estimated that there are more than 350 million HBV carriers in the world [<xref rid="b1-cmh-22-1-183" ref-type="bibr">1</xref>]. HBV is the most common cause of chronic liver disease including liver cirrhosis and hepatocellular carcinoma [<xref rid="b1-cmh-22-1-183" ref-type="bibr">1</xref>]. Recently, potent oral nucleos(t)ide analogues (NA), including entecavir and tenofovir, have been widely used in the treatment of chronic hepatitis B (CHB) [<xref rid="b2-cmh-22-1-183" ref-type="bibr">2</xref>-<xref rid="b5-cmh-22-1-183" ref-type="bibr">5</xref>]. The potent antiviral treatment in patients with CHB can suppress the viral replication and prevent progression to cirrhosis, hepatic failure and development of hepatocellular carcinoma [<xref rid="b6-cmh-22-1-183" ref-type="bibr">6</xref>-<xref rid="b12-cmh-22-1-183" ref-type="bibr">12</xref>]. Furthermore, recent studies demonstrated that regression of liver cirrhosis could be achieved in 74-86% of patients who received NA therapy over 5 years [<xref rid="b8-cmh-22-1-183" ref-type="bibr">8</xref>,<xref rid="b13-cmh-22-1-183" ref-type="bibr">13</xref>]. However, there is little data showing that antiviral therapy can regress esophageal varices in patients with HBV-related liver cirrhosis. Herein, we report a patient with HBV-related liver cirrhosis, whose esophageal varices regressed during entecavir therapy.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 48-year-old man visited outpatient clinic with abdominal discomfort. He was a hepatitis B surface antigen (HBsAg) carrier for long time. The physical examination showed shifting dullness and pitting edema. Laboratory findings were as follows: white blood cell count of 5,100/&#xB5;L (N:4,000-10,000), hemoglobin of 15.3 g/dL (N: 13-17), platelet count of 1.79&#xD7;10<sup>5</sup>/&#xB5;L (N:150,000-450,000), creatinine of 1.2 mg/dL (0.9-1.3), aspartate aminotransferase level of 442 IU/L (N:8-38), alanine aminotransferase (ALT) level of 414 IU/L (N:4-44), total bilirubin of 1.7 mg/dL (N:0.2-1.2), albumin of 3.3 g/dL (N:3.8-5.3), and prothrombin time of 1.1 international normalization ratio (INR) (N:0.88-1.2). HBsAg and hepatitis B e antigen (HBeAg) were positive. Anti-HBs and anti-HCV were negative. Serum level of HBV DNA was 3.87&#xD7;10<sup>5</sup> IU/mL. Ultrasonography showed coarse echogenicity in liver parenchyma, nodularities in liver surface, and moderate amount of ascites, which were suggestive of liver cirrhosis (<xref rid="f1-cmh-22-1-183" ref-type="fig">Fig. 1</xref>). The size of spleen was 10cm in long axis. Esophagogastroduodenoscopic examination showed straight and slightly enlarged tortuous varices in distal esophagus (<xref rid="f2-cmh-22-1-183" ref-type="fig">Fig. 2A</xref>, <xref rid="f2-cmh-22-1-183" ref-type="fig">B</xref>, <xref rid="f2-cmh-22-1-183" ref-type="fig">C</xref>), designated as F1 or F2 according to the general rules for recording endoscopic findings of esophagogastric varices [<xref rid="b14-cmh-22-1-183" ref-type="bibr">14</xref>].</p>
      <p>Entecavir of 0.5 mg/day orally per day was initiated on April 12, 2010. Spironolactone was also started at this time and continued until ascites and pitting edema resolved. Routine laboratory tests, including liver function tests and HBV DNA level were performed every 1-3 months. HBeAg, anti-HBe, AFP, and abdominal ultrasonography were performed every 6 months. Alanine aminotransferase (ALT) were normalized after 3 months of entecavir therapy. Undetectable HBV DNA (&lt; 20 IU/mL) was achieved after 6 months of entevavir therapy. Serum ALT showed persistent normal value and HBV DNA was undetectable until the last follow up (November 18, 2014).</p>
      <p>Follow-up endoscopy, performed on February 9, 2012 and November 28, 2014, showed minimal esophageal varices (<xref rid="f2-cmh-22-1-183" ref-type="fig">Fig. 2D</xref>) and complete regression of esophageal varices (<xref rid="f2-cmh-22-1-183" ref-type="fig">Fig. 2E</xref>, <xref rid="f2-cmh-22-1-183" ref-type="fig">F</xref>), respectively.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>In patients with liver cirrhosis, esophageal varices are present in approximately 50%, and patients without varices develop them at a rate of 5-8% per year [<xref rid="b15-cmh-22-1-183" ref-type="bibr">15</xref>-<xref rid="b17-cmh-22-1-183" ref-type="bibr">17</xref>]. Variceal bleeding, the mortality rate is approximate 15-30% [<xref rid="b18-cmh-22-1-183" ref-type="bibr">18</xref>-<xref rid="b21-cmh-22-1-183" ref-type="bibr">21</xref>], occurs at a yearly rate of 5-15% [<xref rid="b17-cmh-22-1-183" ref-type="bibr">17</xref>,<xref rid="b22-cmh-22-1-183" ref-type="bibr">22</xref>].</p>
      <p>Histological changes in liver cirrhosis have been believed to be irreversible for a long time [<xref rid="b23-cmh-22-1-183" ref-type="bibr">23</xref>]. However, recent studies conducted by Marcellin et al. demonstrated that 74% of patients with HBV-related liver cirrhosis no longer had cirrhosis after 5 years of tenofovir therapy [<xref rid="b8-cmh-22-1-183" ref-type="bibr">8</xref>].</p>
      <p>Nevertheless, little data are available if complications of cirrhosis, such as esophageal varices can regress after antiviral therapy. Several studies reported spontaneous regression of esopahageal varices in patient with spontaneous HBsAg loss or abstinence from alcohol drinking [<xref rid="b24-cmh-22-1-183" ref-type="bibr">24</xref>,<xref rid="b25-cmh-22-1-183" ref-type="bibr">25</xref>] and Koga et al. reported 3 cases whose esophageal varices regressed after lamivudine therapy [<xref rid="b26-cmh-22-1-183" ref-type="bibr">26</xref>]. Recently, we also reported a case, whose esophageal varices regressed after 3 years of sustained virological response following interferon plus ribavirin combination thrapy [<xref rid="b27-cmh-22-1-183" ref-type="bibr">27</xref>]. To the best of our knowledge, this is a first report about regression of esophageal varices during entecavir therapy in patients with HBV-related liver cirrhosis.</p>
      <p>In conclusion, considering previous results [<xref rid="b24-cmh-22-1-183" ref-type="bibr">24</xref>-<xref rid="b27-cmh-22-1-183" ref-type="bibr">27</xref>] and the results of this study, complications of liver cirrhosis, including esophageal varices, can regress after sustained viral suppression in patients with HBV related liver cirrhosis in some patients. Well-designed prospective cohort studies are warranted in near future.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Conflicts of Interest:</bold> The authors have no conflicts to disclose.</p>
      </fn>
    </fn-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ALT</term>
          <def>
            <p>alanine aminotransferase</p>
          </def>
        </def-item>
        <def-item>
          <term>CHB</term>
          <def>
            <p>chronic hepatitis B, HBeAg, hepatitis B e antigen</p>
          </def>
        </def-item>
        <def-item>
          <term>HBsAg</term>
          <def>
            <p>hepatitis B surface antigen</p>
          </def>
        </def-item>
        <def-item>
          <term>HBV</term>
          <def>
            <p>hepatitis B virus</p>
          </def>
        </def-item>
        <def-item>
          <term>NA</term>
          <def>
            <p>nucleos(t)ide analogues</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="b1-cmh-22-1-183">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lavanchy</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures</article-title>
          <source>J Viral Hepat</source>
          <year>2004</year>
          <volume>11</volume>
          <fpage>97</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="pmid">14996343</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-cmh-22-1-183">
        <label>2</label>
        <element-citation publication-type="web">
          <person-group person-group-type="author">
            <collab>Korean Association for the Study of the Liver</collab>
          </person-group>
          <article-title>KASL Clinical Practice Guidelines: Management of chronic hepatitis B, update 2014</article-title>
          <comment>KASL Web site &lt; <ext-link ext-link-type="uri" xlink:href="http://www.kasl.org/bbs/?code=guide">http://www.kasl.org/bbs/?code=guide</ext-link> &gt;. Accessed 2015.01.15</comment>
        </element-citation>
      </ref>
      <ref id="b3-cmh-22-1-183">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>European Association for the Study of the Liver</collab>
          </person-group>
          <article-title>EASL clinical practice guidelines: management of chronic hepatitis B virus infection</article-title>
          <source>J Hepatol</source>
          <year>2012</year>
          <volume>57</volume>
          <fpage>167</fpage>
          <lpage>185</lpage>
          <pub-id pub-id-type="pmid">22436845</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-cmh-22-1-183">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lok</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>McMahon</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Chronic hepatitis B</article-title>
          <source>Hepatology</source>
          <year>2007</year>
          <volume>45</volume>
          <fpage>507</fpage>
          <lpage>539</lpage>
          <pub-id pub-id-type="pmid">17256718</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-cmh-22-1-183">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liaw</surname>
              <given-names>YF</given-names>
            </name>
            <name>
              <surname>Kao</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Piratvisuth</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>HLY</given-names>
            </name>
            <name>
              <surname>Chin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update</article-title>
          <source>Hepatol Int</source>
          <year>2012</year>
          <volume>6</volume>
          <fpage>531</fpage>
          <lpage>561</lpage>
          <pub-id pub-id-type="pmid">26201469</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-cmh-22-1-183">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schiff</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Chao</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Kew Yoon</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bessone</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>SS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B</article-title>
          <source>Clin Gastroenterol Hepatol</source>
          <year>2011</year>
          <volume>9</volume>
          <fpage>274</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="pmid">21145419</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-cmh-22-1-183">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Liaw</surname>
              <given-names>YF</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Schiff</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>CL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B</article-title>
          <source>Hepatology</source>
          <year>2010</year>
          <volume>52</volume>
          <fpage>886</fpage>
          <lpage>893</lpage>
          <pub-id pub-id-type="pmid">20683932</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-cmh-22-1-183">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marcellin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gane</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Buti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Afdhal</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sievert</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>IM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study</article-title>
          <source>Lancet</source>
          <year>2013</year>
          <volume>381</volume>
          <fpage>468</fpage>
          <lpage>475</lpage>
          <pub-id pub-id-type="pmid">23234725</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-cmh-22-1-183">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hosaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Seko</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kawamura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sezaki</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection</article-title>
          <source>Hepatology</source>
          <year>2013</year>
          <volume>58</volume>
          <fpage>98</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="pmid">23213040</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-cmh-22-1-183">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liaw</surname>
              <given-names>YF</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Chow</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Farrell</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>CZ</given-names>
            </name>
            <name>
              <surname>Yuen</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lamivudine for patients with chronic hepatitis B and advanced liver disease</article-title>
          <source>N Engl J Med</source>
          <year>2004</year>
          <volume>351</volume>
          <fpage>1521</fpage>
          <lpage>1531</lpage>
          <pub-id pub-id-type="pmid">15470215</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-cmh-22-1-183">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hosaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Seko</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kawamura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sezaki</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection</article-title>
          <source>Hepatology</source>
          <year>2013</year>
          <volume>58</volume>
          <fpage>98</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="pmid">23213040</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-cmh-22-1-183">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Mak</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Ip</surname>
              <given-names>ZM</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>AT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis</article-title>
          <source>Hepatology</source>
          <year>2013</year>
          <volume>58</volume>
          <fpage>1537</fpage>
          <lpage>1547</lpage>
          <pub-id pub-id-type="pmid">23389810</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-cmh-22-1-183">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsai</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Marcellin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Buti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Washington</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B</article-title>
          <source>Dig Dis Sci</source>
          <year>2015</year>
          <volume>60</volume>
          <fpage>260</fpage>
          <lpage>268</lpage>
          <pub-id pub-id-type="pmid">25179493</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-cmh-22-1-183">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tajiri</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Obara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Onji</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kage</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kitano</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>General rules for recording endoscopic findings of esophagogastric varices (2nd edition)</article-title>
          <source>Dig Endosc</source>
          <year>2010</year>
          <volume>22</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">20078657</pub-id>
        </element-citation>
      </ref>
      <ref id="b15-cmh-22-1-183">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garcia-Tsao</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sanyal</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Grace</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Carey</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis</article-title>
          <source>Hepatology</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>922</fpage>
          <lpage>938</lpage>
          <pub-id pub-id-type="pmid">17879356</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-cmh-22-1-183">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Groszmann</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Garcia-Tsao</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bosch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Grace</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Burroughs</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Planas</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis</article-title>
          <source>N Engl J Med</source>
          <year>2005</year>
          <volume>353</volume>
          <fpage>2254</fpage>
          <lpage>2261</lpage>
          <pub-id pub-id-type="pmid">16306522</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-cmh-22-1-183">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nicolini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Angeloni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rinaldi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>De Santis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Merkel</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Incidence and natural history of small esophageal varices in cirrhotic patients</article-title>
          <source>J Hepatol</source>
          <year>2003</year>
          <volume>38</volume>
          <fpage>266</fpage>
          <lpage>272</lpage>
          <pub-id pub-id-type="pmid">12586291</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-cmh-22-1-183">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Serag</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Everhart</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs</article-title>
          <source>Am J Gastroenterol</source>
          <year>2000</year>
          <volume>95</volume>
          <fpage>3566</fpage>
          <lpage>3573</lpage>
          <pub-id pub-id-type="pmid">11151893</pub-id>
        </element-citation>
      </ref>
      <ref id="b19-cmh-22-1-183">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carbonell</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Pauwels</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Serfaty</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Fourdan</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>L&#xE9;vy</surname>
              <given-names>VG</given-names>
            </name>
            <name>
              <surname>Poupon</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Improved survival after variceal bleeding in patients with cirrhosis over the past two decades</article-title>
          <source>Hepatology</source>
          <year>2004</year>
          <volume>40</volume>
          <fpage>652</fpage>
          <lpage>659</lpage>
          <pub-id pub-id-type="pmid">15349904</pub-id>
        </element-citation>
      </ref>
      <ref id="b20-cmh-22-1-183">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garcia-Tsao</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program</article-title>
          <source>Am J Gastroenterol</source>
          <year>2009</year>
          <volume>104</volume>
          <fpage>1802</fpage>
          <lpage>1829</lpage>
          <pub-id pub-id-type="pmid">19455106</pub-id>
        </element-citation>
      </ref>
      <ref id="b21-cmh-22-1-183">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D&#x2019;Amico</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Garcia-Pagan</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Luca</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bosch</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review</article-title>
          <source>Gastroenterology</source>
          <year>2006</year>
          <volume>131</volume>
          <fpage>1611</fpage>
          <lpage>1624</lpage>
          <pub-id pub-id-type="pmid">17101332</pub-id>
        </element-citation>
      </ref>
      <ref id="b22-cmh-22-1-183">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D&#x2019;Amico</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pagliaro</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bosch</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Pharmacological treatment of portal hypertension: an evidence-based approach</article-title>
          <source>Semin Liver Dis</source>
          <year>1999</year>
          <volume>19</volume>
          <fpage>475</fpage>
          <lpage>505</lpage>
          <pub-id pub-id-type="pmid">10643630</pub-id>
        </element-citation>
      </ref>
      <ref id="b23-cmh-22-1-183">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedman</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Bansal</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <article-title>Reversal of hepatic fibrosis-fact or fantasy?</article-title>
          <source>Hepatology</source>
          <year>2006</year>
          <volume>43</volume>
          <issue>2 Suppl 1</issue>
          <fpage>S82</fpage>
          <lpage>S88</lpage>
          <pub-id pub-id-type="pmid">16447275</pub-id>
        </element-citation>
      </ref>
      <ref id="b24-cmh-22-1-183">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muting</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kalk</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wiewel</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Spontaneous regression of oesophageal varices after long-term conservative treatment. Retrospective study in 20 patients with alcoholic liver cirrhosis, posthepatitic cirrhosis and haemochromatosis with cirrhosis</article-title>
          <source>J Hepatol</source>
          <year>1990</year>
          <volume>10</volume>
          <fpage>158</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="pmid">2332585</pub-id>
        </element-citation>
      </ref>
      <ref id="b25-cmh-22-1-183">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cal&#xE8;s</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Burtin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Oberti</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Spontaneous regression of esophageal varices is a phenomenon that has spontaneously disappeared from our memory</article-title>
          <source>J Hepatol</source>
          <year>1991</year>
          <volume>12</volume>
          <fpage>263</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="pmid">2051008</pub-id>
        </element-citation>
      </ref>
      <ref id="b26-cmh-22-1-183">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koga</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ide</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Oho</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kuwahara</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hino</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ogata</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lamivudine treatment-related morphological changes of esophageal varices in patients with liver cirrhosis</article-title>
          <source>Hepatol Res</source>
          <year>2007</year>
          <volume>37</volume>
          <fpage>503</fpage>
          <lpage>509</lpage>
          <pub-id pub-id-type="pmid">17539992</pub-id>
        </element-citation>
      </ref>
      <ref id="b27-cmh-22-1-183">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HU</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>HJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Complete regression of esophageal varices after interferon plus ribavirin therapy in patients with HCV related liver cirrhosis</article-title>
          <source>J Gastroenterol Hepatol</source>
          <year>2014</year>
          <volume>29</volume>
          <issue>Suppl 3</issue>
          <fpage>195</fpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-cmh-22-1-183" orientation="portrait" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>Abdominal ultrasonographic findings. Intercostal and transverse sonograms (A, B) show coarse parenchymal echogenicity, surface nodularity, and a moderate amount of ascites in the perihepatic space. Subcostal oblique sonograms (C, D) show a large amount of ascites in the widened interlobar fissure, which is considered a typical finding of liver cirrhosis.</p>
      </caption>
      <graphic xlink:href="cmh-22-1-183f1"/>
    </fig>
    <fig id="f2-cmh-22-1-183" orientation="portrait" position="float">
      <label>Figure 2.</label>
      <caption>
        <p>Esophagogastroduodenoscopic findings. Straight to slightly enlarged (A, B) and tortuous varices (C) were observed on the lower esophagus. The esophageal varices had decreased to minimal varices after 2 years of entecavir therapy (D), and had completely disappeared after 4 years of entecavir therapy (E, F).</p>
      </caption>
      <graphic xlink:href="cmh-22-1-183f2"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
